On August 29, 2025, DuPont de Nemours, Inc. agreed to sell its Aramids business (Kevlar® and Nomex®) to Arclin for approximately $1.8 billion, expecting to receive $1.2 billion in cash and a future equity stake valued at $325 million. This event is significant for the company, indicating a strategic move to focus on other areas.